Diagnostics & Tools September 2021

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Baxter International has agreed to acquire Hillrom for approximately $12.3bb
• Pacific Biosciences has raised $300mm in a round of funding
• Mammoth Biosciences has raised $150mm in its series D round of funding led by Redmile Group